Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gentle movement therapy shows promise for leg pain from clogged arteries

NCT ID NCT07250776

Symptom relief Sponsor: Karadeniz Technical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether adding body awareness therapy—relaxation, breathing, and gentle movements—to standard physiotherapy helps people with peripheral artery disease (PAD). Fifty-one adults with PAD were split into two groups: one got standard exercises, the other added body awareness therapy. Researchers measured walking distance, muscle strength, pain, sleep, mood, and more. The goal was to see if this mind-body approach improves both physical and emotional well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Body Awareness Therapy (relaxation, breathing, and movement exercises)
What this could lead to
If it works, this could offer a simple, drug-free way to help people with peripheral artery disease walk farther and feel better day-to-day.
What could go wrong
This is a small, completed trial with only 51 participants, so results may not apply to everyone. The therapy is gentle, so major risks are low, but benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

51 people

The number who actually took part.

Started

Jun 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of Peripheral Artery Disease (PAD) (confirmed by Doppler ultrasonography or Ankle-Brachial Index (ABI) ≤ 0.90). * Being between 40 and 75 years of age. * Having Stage II-III PAD. * Being able to walk independently or with minimal support. * Being fit for exercise with cardiac or pulmonary functions. * Having a cognitive level sufficient to participate in body awareness training. * Having a stable cardiovascular status (not having had an acute cardiac event, myocardial infarction, or stroke) within the last 6 months. * Agreeing to actively participate in the study and signing the informed consent form. Exclusion Criteria: * Having Stage IV PAD. * Individuals unable to carry out daily activities due to severe rest pain. * Serious cardiovascular, pulmonary, neurological, cognitive, or musculoskeletal diseases * Those who have had a myocardial infarction, stroke, or surgery within the last 6 months. * Uncontrolled hypertension, heart failure, respiratory failure, or dependence on oxygen support * Active infection or inflammatory diseases * Uncontrolled diabetes or renal failure * Missed 2 consecutive sessions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Peripheral arterial disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Peripheral arterial disease

Contacts and locations

Locations

  • Karadeniz Technical University, Farabi Hospital

    Trabzon, Türkiye, 34033, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.